Park Nicollet   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Saint Louis Park MN United States (1957)

Organization Overview

First Clinical Trial
2004
NCT00850421
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

International Diabetes Center at Park Nicollet | Park Nicollet Cancer Center | Park Nicollet Eating Disorder Institute | Park Nicollet Foundation | Park Nicollet Health Services | Park Nicollet Melrose Institute | Park Nicollet Methodist Hospital | Park Nicollette, St. Louis, Minnesota

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anorexia (Phase 4)

Anorexia Nervosa (Phase 4)

Anxiety Disorders (Phase 4)

Arthralgia (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 3)

Feeding and Eating Disorders (Phase 4)

Glucose Intolerance (Phase 4)

Hyperglycemia (Phase 4)

Hypoglycemia (Phase 2)

Myalgia (Phase 2)

Thinness (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 14